January 30, 2012
Mr. Justin Dobbie
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Mail Stop 3561
Washington, D.C. 20549
Re: Greenway Medical Technologies, Inc. (the “Registrant”)
Registration Statement on Form S-1
Registration File No. 333-175619
Ladies and Gentlemen:
In connection with the above-captioned Registration Statement, we wish to advise that between January 18, 2012 and January 27, 2012, 6,380 copies of the Preliminary Prospectus dated January 17, 2012 were distributed as follows: 4,210 to prospective underwriters, 2,020 to institutional investors, 0 to prospective dealers, and 150 to others.
We have been informed by the participating underwriters that they will comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
We hereby join in the request of the Registrant that the effectiveness of the above-captioned Registration Statement, as amended, be accelerated to 4:30 p.m. Washington, D.C. time on Wednesday, February 1, 2012, or as soon thereafter as practicable.
Very truly yours,
J.P. MORGAN SECURITIES LLC,
As representatives of the
Prospective Underwriters
| | J.P. MORGAN SECURITIES LLC |
| | By: John Bertone |
| | Name: John Bertone |
| | Title: Vice President |
| | By: John D. Tyree |
| | Name: John D. Tyree |
| | Title: Managing Director |
